Gene · 7913
Papers1,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies. | Head Neck Pathol | 2022 | 35218513 | PubTator, text mining | PubMed |
| Straight to the Point-The Novel Strategies to Cure Pediatric AML. | Int J Mol Sci | 2022 | 35216084 | PubTator, text mining | PubMed |
| Development of Gene Expression-Based Random Forest Model for Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 35205629 | PubTator, text mining | PubMed |
| USP15 in Cancer and Other Diseases: From Diverse Functionsto Therapeutic Targets. | Biomedicines | 2022 | 35203682 | PubTator, text mining | PubMed |
Gilteritinib monotherapy as a transplant bridging option for high risk FLT3-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapy. | Leuk Res Rep | 2022 | 35198371 | PubTator, text mining | PubMed |
| ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression. | Cell Death Differ | 2022 | 35194188 | PubTator, text mining | PubMed |
| Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia. | Blood Cancer Discov | 2022 | 35176137 | PubTator, text mining | PubMed |
| A Long Journey before Cycling: Regulation of Quiescence Exit in Adult Muscle Satellite Cells. | Int J Mol Sci | 2022 | 35163665 | PubTator, text mining | PubMed |
| High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson's disease. | NPJ Parkinsons Dis | 2022 | 35149677 | PubTator, text mining | PubMed |
| Human embryoid bodies as a novel system for genomic studies of functionally diverse cell types. | Elife | 2022 | 35142607 | PubTator, text mining | PubMed |
| DEK, a nuclear protein, is chemotactic for hematopoietic stem/progenitor cells acting through CXCR2 and Gαi signaling. | J Leukoc Biol | 2022 | 35137444 | PubTator, text mining | PubMed |
| A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions. | Acta Neuropathol Commun | 2022 | 35115049 | PubTator, text mining | PubMed |
| Identification of neoantigens for individualized therapeutic cancer vaccines. | Nat Rev Drug Discov | 2022 | 35105974 | PubTator, text mining | PubMed |
| Amphioxus muscle transcriptomes reveal vertebrate-like myoblast fusion genes and a highly conserved role of insulin signalling in the metabolism of muscle. | BMC Genomics | 2022 | 35105312 | PubTator, text mining | PubMed |
| CHAF1A/B mediate silencing of unintegrated HIV-1 DNAs early in infection. | Proc Natl Acad Sci U S A | 2022 | 35074917 | PubTator, text mining | PubMed |
| Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses. | mBio | 2022 | 35073739 | PubTator, text mining | PubMed |
| Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment. | Curr Oncol Rep | 2022 | 35059992 | PubTator, text mining | PubMed |
| A DEK domain-containing protein GhDEK2D mediated Gossypium hirsutum enhanced resistance to Verticillium dahliae. | Plant Signal Behav | 2022 | 35034577 | PubTator, text mining | PubMed |
| RegEnrich gene regulator enrichment analysis reveals a key role of the ETS transcription factor family in interferon signaling. | Commun Biol | 2022 | 35017649 | PubTator, text mining | PubMed |
| EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation. | Nat Commun | 2022 | 35013218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7913/papers?page=18